APUs |
amphiphilic aliphatic polyurethanes |
BDI |
tetramethylene diisocyanate |
BDO |
1,4-butanediol |
BioPUs |
biomedical PUs |
CL |
ε-caprolactone |
CYCLOPHO |
cyclophosphamide |
CS |
chitosan |
CYS |
Cystaminedihydrochloride |
CDI |
bis(2-isocyanatoethyl) disulfide |
DABCO |
1,4-diazabicyclo-[2.2.2]-octane |
1,4-DAB |
1,4-diaminobutane |
1,2-DAE |
1,2-diaminoethane |
1,6-DAH |
1,6-diaminohexane |
1,8-DAO |
1,8-diaminooctane |
DBTDL |
dibutyltin dilaurate |
DBTDO |
dibutyltin dioctanate |
DEG |
diethylene glycol |
DDS/DDSs |
drug delivery system(s) |
DMPA |
2,2-bis(hydroxymethyl)propionic acid |
DOX |
doxorubicin |
EG |
ethylene glycol |
ECG |
epigallocatechin gallate |
FA |
folic acid |
5-FU |
5-fluorouracil |
GG |
glycolide |
GEF |
gefitinib |
GSH |
glutathione |
HDI |
hexamethylene diisocyanate |
HMDI |
dicyclohexylmethane 4,4′-diisocyanate |
HEP |
bis-1,4-(hydroxyethyl) piperazine |
HPEG |
hydrazone-ended methoxyl-poly(ethylene glycol) |
HPCL |
hydrazone-embedded poly(ε-caprolactone) diol |
IC/ICs |
diisocyanate/diisocyanates |
IPDI |
isophorone diisocyanate |
LA |
lactide |
LCST |
lower critical solution temperature |
LDI |
L-Lysine diisocyanate ethyl ester |
L-LYS |
L-lysine |
L-LYS-GQA |
L-lysine-derivatized gemini quaternary ammonium salts with two primary amine groups |
L-LYS-ABA-ABA tripeptide |
L-lysine-γ-aminobutyric acid-γ-aminobutyric acid tripeptide |
mPEG |
methoxyl-poly(ethylene glycol) |
MDEA |
N-methyl-diethanolamine |
MDI |
4,4′-methylenebis(phenyl isocyanate) |
EG |
ethylene glycol |
METX |
Methotrexate |
bis-MPA |
2,2-bis(hydroxymethyl)-propionic acid |
NP |
nanoparticles |
O-DTT |
trans-4,5-dihydroxy-1,2-dithiane |
OEDA |
dihydroxy(polyethylene adipate) |
PACL |
paclitaxel |
PBS |
phosphate buffered saline |
PCL |
poly(ε-caprolactone) |
PEG-PU(SS)-PEG |
polyurethane with disulfide bonds and PEG fragments |
PEOtz-OH |
poly(2-ethyl-2-oxazoline) |
PHBHx |
poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) |
PLGA |
copolymer of lactide and glycolide |
PDO |
1,3-propanediol |
PEG |
poly(ethylene glycol) |
PLA |
polylactide |
PLACL |
copolymer of lactide and ε-caprolactone |
PLA-SS-PLA |
PLA with disulfide bonds |
PNIPAAm-g-chitosan |
poly(N-isopropylacrylamide)-grafted-chitosan |
POEUs |
poly(ortho ester urethanes) |
POx |
poly(2-oxazoline)s |
PPG |
poly(propylene glycol) |
PPG-N3
|
azide-grafted PEG |
PPEG |
Propargyl-grafted PEG |
PPS |
poly(1,3-propylene succinate) diols |
PTMC |
poly(trimethylene carbonate) |
PTMC-SS-PTMC |
PTMC with disulfide bonds |
PTMG |
poly(tetramethylene ether) glycol |
PUs |
polyurethanes |
PU-DDSs |
polyurethane drug delivery systems |
PU-Prodrugs |
polyurethane prodrugs |
PU-SS-COOH |
polyurethane obtained from PEG-1000, PCL-2000, HDI, CYS and DMPA |
PU-SS-COOH-NH2
|
product of condensation reaction between the PU-SS-COOH and 1,6-diaminohexane |
ROP |
ring-opening polymerization |
SnOct2
|
tin(II) 2-ethylhexanoate |
SPION |
superparamagnetic iron oxide nanoparticles |
TDI |
toluene 2,4-diisocyanate |
TMC |
trimethylene carbonate |
TMZ |
temozolomide |
WPU |
waterborne polyurethane dispersions |